Developing a provisional definition of flare in patients with established gout

Arthritis and Rheumatism

Volumn 64, Issue 5, 2012, Pages 1508-1517

  Gaffo, Angelo L ^a   Schumacher, H Ralph ^b   Saag, Kenneth G ^a   Taylor, William J ^c   Dinnella, Janet ^d   Outman, Ryan ^a   Chen, Lang ^a   Dalbeth, Nicola ^e   Sivera, Francisca ^f   Vázquez Mellado, Janitzia ^g   Chou, Chung Tei ^h   Zeng, Xuejun ⁱ   Perez Ruiz, Fernando ^j   Kowalski, Sergio C ^k   Goldenstein Schainberg, Claudia ^k   Chan, Lan ^l   Bardin, Thomas ^m   Singh, Jasvinder A ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF AUCKLAND   (New Zealand)

^f HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^g SECRETARÍA DE SALUD   (Mexico)

^h TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

ⁱ PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^j HOSPITAL DE CRUCES   (Spain)

^k UNIVERSITY OF SÃO PAULO   (Brazil)

^l PENN PRESBYTERIAN MEDICAL CENTER   (United States)

^m HÔPITAL LARIBOISIÈRE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTHRALGIA; ARTICLE; CLINICAL FEATURE; DISEASE EXACERBATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GOUT; HISPANIC; HUMAN; JOINT SWELLING; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REST; RHEUMATOLOGY; SELF REPORT; SENSITIVITY AND SPECIFICITY;

EID: 84860487942     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.33483     Document Type: Article

References (34)

1. Becker MA, Schumacher HR Jr, Wortmann RL, MacDonald PA, Eustace D, Palo WA, et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 2005; 353: 2450-61.
2. Li-Yu J, Clayburne G, Sieck M, Beutler A, Rull M, Eisner E, et al. Treatment of chronic gout: can we determine when urate stores are depleted enough to prevent attacks of gout? J Rheumatol 2001; 28: 577-80.
3. Neogi T, Hunter DJ, Chaisson CE, Allensworth-Davies D, Zhang Y,. Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study. J Rheumatol 2006; 33: 104-9.
4. Sarawate CA, Patel PA, Schumacher HR, Yang W, Brewer KK, Bakst AW,. Serum urate levels and gout flares: analysis from managed care data. J Clin Rheumatol 2006; 12: 61-5.
5. Shoji A, Yamanaka H, Kamatani N,. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum 2004; 51: 321-5.
6. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF,. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977; 20: 895-900.
7. Pincus T, Summey JA, Soraci SA Jr, Wallston KA, Hummon NP,. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 1983; 26: 1346-53.
8. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A,. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997; 40: 1202-9.
9. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, and the CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54: 2665-73.
10. Doward LC, Spoorenberg A, Cook SA, Whalley D, Helliwell PS, Kay LJ, et al. Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 2003; 62: 20-6.
11. McKenna SP, Doward LC, Whalley D, Tennant A, Emery P, Veale DJ,. Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis 2004; 63: 162-9.
12. Aletaha D,. From the item to the outcome: the promising prospects of PROMIS. Arthritis Res Ther 2010; 12: 104.
13. Taylor WJ, Schumacher HR Jr, Baraf HS, Chapman P, Stamp L, Doherty M, et al. A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout. Ann Rheum Dis 2008; 67: 888-91.
14. Taylor WJ, Shewchuk R, Saag KG, Schumacher HR Jr, Singh JA, Grainger R, et al. Toward a valid definition of gout flare: results of consensus exercises using Delphi methodology and cognitive mapping. Arthritis Rheum 2009; 61: 535-43.
15. Fries JF, Spitz PW, Young DY,. The dimensions of health outcomes: the Health Assessment Questionnaire, disability and pain scales. J Rheumatol 1982; 9: 789-93.
16. Taylor WJ, Colvine K, Gregory K, Collis J, McQueen FM, Dalbeth N,. The Health Assessment Questionnaire Disability Index is a valid measure of physical function in gout. Clin Exp Rheumatol 2008; 26: 620-6.
17. Brunner HI, Klein-Gitelman MS, Higgins GC, Lapidus SK, Levy DM, Eberhard A, et al. Toward the development of criteria for global flares in juvenile systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2010; 62: 811-20.
18. Magni-Manzoni S, Ruperto N, Pistorio A, Sala E, Solari N, Palmisani E, et al. Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis. Arthritis Rheum 2008; 59: 1120-7.
19. Petri M, Genovese M, Engle E, Hochberg M,. Definition, incidence, and clinical description of flare in systemic lupus erythematosus: a prospective cohort study. Arthritis Rheum 1991; 34: 937-44.
20. Petri M, Kasitanon N, Lee SS, Link K, Magder L, Bae SC, et al. Systemic Lupus International Collaborating Clinics renal activity/response exercise: development of a renal activity score and renal response index. Arthritis Rheum 2008; 58: 1784-8.
21. Ruperto N, Ozen S, Pistorio A, Dolezalova P, Brogan P, Cabral DA, et al, for the Paediatric Rheumatology International Trials Organisation (PRINTO). EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation. Ann Rheum Dis 2010; 69: 790-7.
22. Ruperto N, Ravelli A, Oliveira S, Alessio M, Mihaylova D, Pasic S, et al, for the Paediatric Rheumatology International Trials Organization (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG). The Pediatric Rheumatology International Trials Organization/American College of Rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the definition of improvement. Arthritis Rheum 2006; 55: 355-63.
23. Ruperto N, Ravelli A, Pistorio A, Ferriani V, Calvo I, Ganser G, et al, for the Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG). The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study. Arthritis Rheum 2008; 59: 4-13.
24. Bloch DA, Moses LE, Michel BA,. Statistical approaches to classification: methods for developing classification and other criteria rules. Arthritis Rheum 1990; 33: 1137-44.
25. Bertail P, Clemencon S, Vayatis N,. On constructing accurate confidence bands for ROC curves through smooth resampling. URL:.
26. Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990; 33: 1129-34.
27. Calabrese LH, Michel BA, Bloch DA, Arend WP, Edworthy SM, Fauci AS, et al. The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. Arthritis Rheum 1990; 33: 1108-13.
28. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33: 1122-8.
29. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33: 1101-7.
30. Lightfoot RW Jr, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990; 33: 1088-93.
31. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990; 33: 1094-100.
32. Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum 1990; 33: 1114-21.
33. Eliot M, Azzoni L, Firnhaber C, Stevens W, Glencross DK, Sanne I, et al. Tree-based methods for discovery of association between flow cytometry data and clinical endpoints. Adv Bioinformatics 2009; 2009: 235320.
34. Boers M, Brooks P, Strand CV, Tugwell P,. The OMERACT filter for outcome measures in rheumatology. J Rheumatol 1998; 25: 198-9.